IL197445A - Processes for the preparation of benzoic acids 1, 2, 4-oxadiazole - Google Patents

Processes for the preparation of benzoic acids 1, 2, 4-oxadiazole

Info

Publication number
IL197445A
IL197445A IL197445A IL19744509A IL197445A IL 197445 A IL197445 A IL 197445A IL 197445 A IL197445 A IL 197445A IL 19744509 A IL19744509 A IL 19744509A IL 197445 A IL197445 A IL 197445A
Authority
IL
Israel
Prior art keywords
processes
preparation
benzoic acids
oxadiazole benzoic
oxadiazole
Prior art date
Application number
IL197445A
Other languages
English (en)
Hebrew (he)
Other versions
IL197445A0 (en
Original Assignee
Ptc Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Inc filed Critical Ptc Therapeutics Inc
Publication of IL197445A0 publication Critical patent/IL197445A0/en
Publication of IL197445A publication Critical patent/IL197445A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL197445A 2006-09-08 2009-03-05 Processes for the preparation of benzoic acids 1, 2, 4-oxadiazole IL197445A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84359506P 2006-09-08 2006-09-08
PCT/US2007/019561 WO2008030570A1 (en) 2006-09-08 2007-09-06 Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Publications (2)

Publication Number Publication Date
IL197445A0 IL197445A0 (en) 2009-12-24
IL197445A true IL197445A (en) 2014-01-30

Family

ID=38935880

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197445A IL197445A (en) 2006-09-08 2009-03-05 Processes for the preparation of benzoic acids 1, 2, 4-oxadiazole

Country Status (24)

Country Link
US (2) US7678922B2 (https=)
EP (1) EP2059513B1 (https=)
JP (2) JP5955494B2 (https=)
KR (1) KR101466368B1 (https=)
CN (1) CN101535284B (https=)
AR (3) AR062715A1 (https=)
AU (1) AU2007292915B2 (https=)
BR (1) BRPI0716996B8 (https=)
CA (2) CA2662749C (https=)
CL (1) CL2007002606A1 (https=)
DK (1) DK2059513T3 (https=)
ES (1) ES2404348T3 (https=)
IL (1) IL197445A (https=)
MX (1) MX2009002439A (https=)
MY (1) MY148598A (https=)
NZ (2) NZ575511A (https=)
PE (2) PE20120669A1 (https=)
PL (1) PL2059513T3 (https=)
PT (1) PT2059513E (https=)
RU (1) RU2495030C2 (https=)
TW (1) TWI482761B (https=)
UA (1) UA99265C2 (https=)
WO (1) WO2008030570A1 (https=)
ZA (1) ZA200901782B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4101846B1 (en) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
PL2402002T3 (pl) 2005-04-08 2018-11-30 Ptc Therapeutics, Inc. Kompozycje zawierające kwas 1,2,4-oksadiazolobenzoesowy i ich zastosowania do leczenia chorób związanych z przedwczesnym kodonem stop
EP2387995A1 (en) 2006-03-30 2011-11-23 PTC Therapeutics, Inc. Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
UA99265C2 (ru) * 2006-09-08 2012-08-10 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способ получения 1,2,4-оксадиазолбензойной кислоты и ее производных (варианты)
US8101641B2 (en) 2006-09-25 2012-01-24 Ptc Therapeutics, Inc. Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof
NZ575795A (en) * 2006-09-25 2012-03-30 Ptc Therapeutics Inc Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
MX2009003909A (es) 2006-10-12 2009-05-25 Ptc Therapeutics Inc Métodos para dosificar un compuesto 1,2,4, - oxadiazol oralmente activo para el tratamiento de supresión de la mutación finalizadora.
CN101714009A (zh) * 2009-05-14 2010-05-26 翁印嵩 集成通用电话功能的计算机
ES2610362T3 (es) 2011-01-25 2017-04-27 Viviabiotech, S.L. Derivados de 1,2,4-oxadiazol como fármacos moduladores del receptor para el péptido glp-1
EP2867230B1 (en) 2012-07-02 2020-02-12 Monsanto Technology LLC Process for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles
TWI695717B (zh) 2014-03-06 2020-06-11 美商 Ptc 治療公司 1,2,4-二唑苯甲酸之鹽及醫藥組合物
CN105461650B (zh) * 2014-09-12 2018-04-13 杭州普晒医药科技有限公司 一种噁二唑化合物的溶剂化物及其制备方法
CN106316885B (zh) * 2015-07-03 2019-02-12 普济生物科技(台州)有限公司 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法
CN108348527A (zh) 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法
TW201808922A (zh) 2016-06-20 2018-03-16 台灣神隆股份有限公司 製備阿塔魯仁及其中間體的方法
WO2020128816A2 (en) 2018-12-20 2020-06-25 Pfizer Inc. Pharmaceutical compositions and methods comprising a combination of a benzoxazole transthyretin stabilizer and an additional therapeutic agent
EP4473971A3 (en) 2019-04-10 2025-02-19 PTC Therapeutics, Inc. Method for treating nonsense mutation mediated duchenne muscular dystrophy in pediatric patients
WO2022112919A1 (en) 2020-11-25 2022-06-02 Pfizer Inc. (aza)benzothiazolyl substituted pyrazole compounds
CN113045510B (zh) * 2021-03-31 2022-05-27 北京大学生命科学华东产业研究院 一种阿塔鲁伦的制备方法
CN114920667B (zh) * 2022-06-30 2024-06-21 湖南大学 一种阿塔鲁伦酯的电化学制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801509A1 (de) * 1978-01-12 1979-07-19 Schering Ag 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
DE3905242A1 (de) * 1989-02-21 1990-08-23 Basf Ag Verfahren zur herstellung von phenyloxdiazolylanilinen
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
DE4425794A1 (de) * 1994-07-21 1996-01-25 Basf Ag Nitrofarbstoffe
US6660753B2 (en) 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
KR20040004705A (ko) 2001-06-08 2004-01-13 시토비아 인크. 카스파제의 활성제 및 아폽토시스의 유도제로서의 치환된3-아릴-5-아릴-[1,2,4]-옥사디아졸과 유사체 및 이의 용도
MY151199A (en) 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
MXPA05001592A (es) 2002-08-09 2005-05-05 Astrazeneca Ab Oxadiazoles como moduladores de receptor-5 de glutamato metabotropico.
GB0303503D0 (en) 2003-02-14 2003-03-19 Novartis Ag Organic compounds
EP4101846B1 (en) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
US20050075375A1 (en) 2003-05-14 2005-04-07 Anadys Pharmaceuticals, Inc. Heterocyclic compounds for treating hepatitis C virus
PL2402002T3 (pl) * 2005-04-08 2018-11-30 Ptc Therapeutics, Inc. Kompozycje zawierające kwas 1,2,4-oksadiazolobenzoesowy i ich zastosowania do leczenia chorób związanych z przedwczesnym kodonem stop
UA99265C2 (ru) * 2006-09-08 2012-08-10 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способ получения 1,2,4-оксадиазолбензойной кислоты и ее производных (варианты)

Also Published As

Publication number Publication date
AU2007292915B2 (en) 2012-07-26
AR107474A2 (es) 2018-05-02
BRPI0716996B1 (pt) 2021-02-09
PL2059513T3 (pl) 2013-06-28
RU2495030C2 (ru) 2013-10-10
CN101535284B (zh) 2014-12-10
BRPI0716996A2 (pt) 2013-10-08
US20080139818A1 (en) 2008-06-12
AU2007292915A1 (en) 2008-03-13
TW200823180A (en) 2008-06-01
KR20090054464A (ko) 2009-05-29
US20100063297A1 (en) 2010-03-11
MY148598A (en) 2013-05-15
CA2662749A1 (en) 2008-03-13
KR101466368B1 (ko) 2014-11-27
RU2009113019A (ru) 2010-10-20
MX2009002439A (es) 2009-03-27
NZ575511A (en) 2012-02-24
EP2059513B1 (en) 2013-01-23
WO2008030570A1 (en) 2008-03-13
JP5955494B2 (ja) 2016-07-20
CA2662749C (en) 2015-01-20
CL2007002606A1 (es) 2008-04-18
PT2059513E (pt) 2013-04-30
ZA200901782B (en) 2010-06-30
EP2059513A1 (en) 2009-05-20
CN101535284A (zh) 2009-09-16
PE20080771A1 (es) 2008-06-13
CA2842625A1 (en) 2008-03-13
AR118922A2 (es) 2021-11-10
JP2010502715A (ja) 2010-01-28
UA99265C2 (ru) 2012-08-10
ES2404348T3 (es) 2013-05-27
US8367841B2 (en) 2013-02-05
BRPI0716996B8 (pt) 2021-05-25
AR062715A1 (es) 2008-11-26
IL197445A0 (en) 2009-12-24
DK2059513T3 (da) 2013-05-06
NZ598012A (en) 2013-08-30
US7678922B2 (en) 2010-03-16
TWI482761B (zh) 2015-05-01
PE20120669A1 (es) 2012-06-01
HK1134094A1 (en) 2010-04-16
CA2842625C (en) 2016-07-12
JP2014193896A (ja) 2014-10-09

Similar Documents

Publication Publication Date Title
IL197445A0 (en) Processes for the preparation of 1,2,4-oxadiazole benzoic acids
DK3872058T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
PL1993985T3 (pl) Sposób wytwarzania 1,2-propanodiolu
IL202473A (en) Carboxylic acids are converted to benzoylamino-indene-2, their compounds and medical preparations containing these acids
IL195178A0 (en) 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
IL195177A0 (en) 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
IL188330A0 (en) Processes for the preparation of
IL195176A0 (en) 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
SG10201508066VA (en) Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
IL226412A0 (en) Methods for the preparation of cycloalkylcarboxyamido-pyridine benzoic acids
ZA201008097B (en) Process for the preparation of 2,3,3,3-trifluoropropene
PL2035358T3 (pl) Sposób wytwarzania 1,2-dichloroetanu
PL2035357T3 (pl) Proces wytwarzania 1,2-dichloroetanu
IL192670A0 (en) 1,3-dioxane carboxylic acids
IL183379A0 (en) Processes for the preparation of linezolid intermediate
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
EP1922345A4 (en) PROCESS FOR THE PREPARATION OF COPOLYMER-1
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
IL190325A (en) A process for making loopfin
EP1996192A4 (en) PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4
IL199239A0 (en) Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-
ZA200601910B (en) Process for the preparation of organosilances
ZA200710665B (en) Processes for the preparation of paclitaxel
IL187824A0 (en) Processes for the preparation of paclitaxel
ZA201003264B (en) Method for the preparation of 2 chloro1,1,1,2,3,3,3 heptafluopropane

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed